Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RaP-AF
NCT04513509Completed
- Sponsor
- National Taiwan University Hospital
- Start
- Oct 2020
- Primary completion
- Jun 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Open-label, single-arm trial of atenolol, bisoprolol, metoprolol, nebivolol, propranolol and 3 more in Atrial fibrillation (AFib), sponsored by National Taiwan University Hospital. Primary endpoint: Change of Maximal Oxygen consumption at 6 months. Started Oct 2020; status: completed.
02
Drugs
atenololbisoprololmetoprololnebivololpropranolol
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT04513509.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04513509.